Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Slastnikova ID"'
Autor:
SY Martsevich, VA Vygodin, DO Rumiantsev, Metelitsa Vi, Egorov Lv, VK Piotrovskii, Slastnikova Id
Publikováno v:
British Journal of Clinical Pharmacology. 29:339-346
1. The possibility of development of tolerance to the anti-ischaemic and anti-anginal effects of nifedipine during sustained administration for 2 months was studied in 15 patients with stable angina pectoris by means of repeated exercise tests on a t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32728dd77a9b1edbcfe97c6145e39429
https://doi.org/10.1111/j.1365-2125.1990.tb03645.x
https://doi.org/10.1111/j.1365-2125.1990.tb03645.x
Autor:
Martsevich, SY, Metelitsa, VI, Rumiantsev, DO, Piotrovskii, VK, Slastnikova, ID, Egorov, LV, Vygodin, VA
Publikováno v:
British Journal of Clinical Pharmacology; 1990, Vol. 29 Issue 3, p339-346, 8p
Autor:
Rumiantsev, DO, Piotrovskii, VK, Metelitsa, VI, Slastnikova, ID, Martsevich Yu, S., Kokurina, EV
Publikováno v:
British Journal of Clinical Pharmacology; 1989, Vol. 28 Issue 3, p357-361, 5p
Publikováno v:
British Journal of Clinical Pharmacology; 1986, Vol. 22 Issue 5, p606-609, 4p
Publikováno v:
British Journal of Clinical Pharmacology. 28:357-361
Serum free fractions of nifedipine, verapamil and some of their metabolites were measured in patients with ischaemic heart disease receiving single oral dose and chronic monotherapy and were compared with those obtained in vitro. The percentages of u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b7e97d48984421b658092af47682c1a
https://doi.org/10.1111/j.1365-2125.1989.tb05438.x
https://doi.org/10.1111/j.1365-2125.1989.tb05438.x
Publikováno v:
British journal of clinical pharmacology. 22(5)
The influence of chronic verapamil treatment on antipyrine elimination was studied in eight angina patients. Antipyrine half-life (mean +/- s.d.) was 13.1 +/- 1.15 h at the start of therapy and 16.6 +/- 3.05 h (P less than 0.05) during chronic oral a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b721a1a21c536897e3a3b0ba1563ad7f
https://pubmed.ncbi.nlm.nih.gov/3790408
https://pubmed.ncbi.nlm.nih.gov/3790408
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 1998; Vol. 70 (8), pp. 21-5.
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 1994 May-Jun; Vol. 57 (3), pp. 47-50.
Autor:
Metelitsa VI, Martsevich SIu, Kutishenko NP, Kozyreva MP, Blagodatskikh SV, Simkhaev LS, Slastnikova ID, Vakulovskaia MK
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 1994; Vol. 66 (8), pp. 22-5.
Autor:
Metelitsa VI; Department of Preventive Pharmacology, USSR Research Center for Preventive Medicine, Moscow., Martsevich SYu, Kozyreva MP, Slastnikova ID
Publikováno v:
The American journal of cardiology [Am J Cardiol] 1992 Feb 01; Vol. 69 (4), pp. 291-6.